GUILLERMO
LÓPEZ VIVANCO
Chercheur jusqu' 2022
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas MD Anderson Cancer Center (3)
2020
-
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
The Lancet Oncology, Vol. 21, Núm. 11, pp. 1413-1422
2012
2003
-
Chemotherapy for Bladder Cancer [6] (multiple letters)
New England Journal of Medicine